Michael Lilly
Endowed Chair, Oliver S. and Jennie R. Donaldson Charitable Trust Endowed Chair · Medical University of South Carolina College of Medicine
Credentials: · · ·
History
- 1975–1978
Internal Medicine
Research
Effective and selective targeting of leukemia cells using a TORC1/2 kinase inhibitor
Nature Medicine · 2010 · 302 citations
FEBS Letters · 2004 · 296 citations
Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer
PLoS ONE · 2012 · 257 citations
21 papers
- MZ
8 papers · 4 as a resident
7 papers
6 papers
6 papers
4 papers
- JS
4 papers
4 papers
Grants
- 2021–2026
Ethnicity-Determined T Cell Responses and GARP/TGFbeta1 Signaling in Prostate Cancer
National Cancer Institute · R01
PI · $370.6K · University of California-Irvine
- 2016–2025
National Institute on Minority Health and Health Disparities · U54
PI · $8M · University of Southern California
- 2015–2023
CDK8/19 Inhibitors for Therapy of Advanced Prostate Cancer
National Cancer Institute · R44
PI · $2M · Senex Biotechnology, Inc.
- 2013–2023
MUSC/HCC Paul Calabresi Clinical Oncology Career Development Program
National Cancer Institute · K12
Contact PI · $3M · Medical University of South Carolina
Clinical trials
- 2020–2024
Addition of Opaganib to Androgen Antagonists in Patients With mCRPC
Principal investigator · Completed · Phase 2
Medical University of South Carolina
- 2019–2023
Clonal Emergence and Regression During Radium-223 Therapy for Metastatic Prostate Cancer
Principal investigator · Completed
Medical University of South Carolina
- 2019–2021
Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients
Principal investigator · Terminated · Phase 1, Phase 2
Medical University of South Carolina
- 2018
Principal investigator · Withdrawn · Phase 1
Medical University of South Carolina